CompletedPhase 3NCT01969708
Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)
Studying Central retinal vein occlusion
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Emmes Company, LLC
- Principal Investigator
- Ingrid U Scott, M.D., M.P.H.Penn State College of Medicine
- Intervention
- aflibercept(drug)
- Enrollment
- 362 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2014 – 2021
Study locations (30)
- Retinal Consultants of AZ, Phoenix, Arizona, United States
- Retina Centers, P.C., Tucson, Arizona, United States
- Northern California Retina Vitreous Associates, Mountain View, California, United States
- East Bay Retina Consultants, Inc., Oakland, California, United States
- Southern California Desert Retina Consultants, Palm Desert, California, United States
- University of California Davis, Medical Center, Sacramento, California, United States
- Retinal Consultants Medical Group, Inc., Sacramento, California, United States
- University of California, San Francisco, San Francisco, California, United States
- New England Retina Associates, New London, Connecticut, United States
- Retina Group of Florida, Fort Lauderdale, Florida, United States
- National Ophthalmic Research Institute, Fort Myers, Florida, United States
- University of Florida, Dept of Ophthalmology, Jacksonville, Florida, United States
- Florida Retina Consultants, Lakeland, Florida, United States
- Sarasota Retina Institute, Sarasota, Florida, United States
- Center for Retina and Macular Disease, Winter Haven, Florida, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Eye Institute (NEI) · Milton S. Hershey Medical Center · University of Wisconsin, Madison
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01969708 on ClinicalTrials.govOther trials for Central retinal vein occlusion
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE4NCT07456826Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsHarrow Inc
- ENROLLING BY INVITATIONNANCT07318428AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and GlaucomaInje University
- RECRUITINGNCT07308639DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. The Project Also Explores New Ways to Collect and Use Publicly Available Healthcare Information.Bayer
- RECRUITINGPHASE2NCT07259928Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein OcclusionAnnexin Pharmaceuticals AB
- RECRUITINGEARLY PHASE1NCT04008121Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein SodiumMediBeacon
- RECRUITINGNCT07550777Serum Cholinesterases, Paraoxonase, and Cardiovascular Risk After Intravitreal BevacizumabAtaturk University
- RECRUITINGPHASE2NCT07205887A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVOEyeBiotech Ltd.
- RECRUITINGNANCT07002372Effect of Video Viewing on Intravitreal Injection ExperienceSecond Affiliated Hospital, School of Medicine, Zhejiang University